The role of EBV in MS pathogenesis

International MS Journal

Volumn 13, Issue 2, 2006, Pages 52-57

  Christensen, Tove ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Co factor; Epstein Barr virus; Molecular mimicry; Multiple sclerosis; Seroepidemiology

Indexed keywords

CAPSID PROTEIN; CELL NUCLEUS ANTIGEN; EARLY ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PREVALENCE; RETROVIRUS; REVIEW; VIRUS REACTIVATION;

ANTIBODIES, VIRAL; HERPES SIMPLEX; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS;

EID: 33646778802     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Hafler D. Multiple sclerosis. J Clin Invest 2004; 113: 788-794.
2. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-468.
3. Kornek B, Lassmann H. Neuropathology of multiple sclerosis - new concepts. Brain Res Bull 2003; 61: 321-326.
4. Hogancamp WE, Rodriguez M, Weinshenker BG. The epidemiology of multiple sclerosis. Mayo Clin Proc 1997; 72: 871-878.
5. Sadovnick AD, Yee, IML, Ebers GC, Risch NJ. Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998; 50: 719-723.
6. Olerup O, Hillert J. HLA class-II associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38: 1-15.
7. Akesson E, Oturai A, Berg J, Fredriksor S, Andersen O, Harbo HF et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun 2002; 3: 279-285.
8. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 1998; 121: 1869-1887.
9. AMB Community. Serono Identifies 80 Genes Involved in Multiple Sclerosis Using 100,000 SNPs. Available at: http://microarraybulletin.com/ community/?p=17. Last accessed 3 March 2006.
10. Haahr S, Munch M, Christensen T, Moller-Larsen A, Hvas J. Cluster of multiple sclerosis patients from Danish community. Lancet 1997; 349: 923.
11. Kurtzke JF, Heltberg A. Multiple sclerosis in the Faroe Islands: on epitome. J Clin Epidemiol 2001; 54: 1-22.
12. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15: 179-211.
13. Simmons A. Herpesvirus and multiple sclerosis. Herpes 2001; 8: 60-03.
14. Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 2005; 81: 103-107.
15. Prober C. Sixth disease and the ubiquity of human herpesviruses. N Engl J Med 2005; 352: 753-755.
16. Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 2001; 19: 3097-3103.
17. Bhaduri-McIntosh S. Human herpesvirus-8: clinical features of an emerging viral pathogen. Pediatr Intect Dis J 2005; 24: 81-82.
18. Clark DA, Freeland JML, Mackie PLK, Jarrett RF, Onions DE. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 1993; 168: 251-252.
19. Pass RF: Cytomegalovirus. In: Fields Virology, 4th edn (Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B et al. eds). Philadelphia: Lippincott Williams & Wilkins 2001; pp2675-2706.
20. Munch, M, Hvas J, Christensen T, Møller-Larsen A, Haahr S. The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand 1997; 95 (Suppl 169): 59-64.
21. Haahr S, Plesner AM, Vestergaard BF, Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 2004; 109: 270-275.
22. Haahr S, Koch-Henriksen N, Moller-Larsen A, Eriksen LS, Andersen HM. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler 1995; 1: 73-77.
23. Casetta I, Granieri E. Clinical infections and multiple sclerosis: contributions from analytical epidemiology. J Neurovirol 2000; 6 (Suppl 2): 147-151.
24. Munch M, Hvas J, Christensen T, Moller-Larsen A, Haahr S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 1998; 98: 395-399.
25. Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291: 1875-1879.
26. Wagner HJ, Hennig H, Jabs WJ, Siekhaus A, Wessel K et al. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis. Viral Immunol 2000; 13: 497-502.
27. Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000; 11: 220-224.
28. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019-3026.
29. Christensen T, Sorensen PD, Hansen HJ, Moller-Larsen A. Antibodies against a human endogenous retrovirus and the preponderance of Env splice variants in multiple sclerosis patients. Mult Scler 2003; 9:6-15.
30. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998; 4: 111-117.
31. Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42: 1798-1804.
32. Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Bussow K et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: 1352-1360.
33. Rand KH, Houck H, Denslow ND, Heilman KM. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 2000; 173: 32-39.
34. Derfuss T, Hohlfeld R, Meinl E. Intrathecal antibody (IgG) production against human herpes-virus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol 2005; 252: 968-971.
35. Wandinger KP, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000; 55: 178-184.
36. Wagner HJ, Munger KL, Ascherio A. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur J Neurol 2004; 11: 833-834.
37. Ordonez G, Pineda B, Garcia-Navarrete R, Sotelo J. Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 2004; 61: 529-532.
38. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 1990; 2: 249-258.
39. Virtanen JO, Zabriskie JB, Siren V, Friedman JE, Lyons MJ, Vaheri A et al. Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med Sci Monit 2005; 11: BR 84-87.
40. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
41. Hafler DA. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J Clin Invest 1999; 104: 527-529.
42. Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3: 940-943.
43. Holmoy T, Kvale EO, Vartdal F. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol 2004; 10: 278-283.
44. Hollsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 2003; 132: 137-143.
45. Vaughan JH. The Epstein-Barr virus in autoimmunity. Springer Semin Immunopathol 1995; 17: 203-230.
46. Bech E, Lycke J, Gadeberg P, Hansen HJ, Malmestrom C et al. A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 2002; 58: 31-36.
47. Christensen T, Jensen AW, Munch M, Haahr S, Dissing Sørensen P et al. Characterization of retrovirus from multiple sclerosis patients. Acta Neurol Scand 1997; 95 (Suppl 169): 49-58.